Gensia extends laryngeal mask airway (LMA) distribution agreement:
This article was originally published in Clinica
Executive Summary
San Diego-based Gensia has extended its distribution agreement with the Laryngeal Mask Co for its laryngeal mask airway (LMA). The product was introduced by Gensia in the US in 1992. Gensia has also obtained exclusive US distribution rights to three new airway management products under development at Laryngeal Mask (formerly Cyprus-based Intavent). The LMA maintains an open airway in patients receiving general anaesthesia and is well suited to outpatient surgery, says Gensia. It does not require manual maintenance. Outpatient surgery accounted for 64% of total surgery in the US in 1993 and is set to increase to 70% by 1996, says the company.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.